|
|
||||||||
Articles |
1
Laboratoire de Biochimie Hormonale, Hôpital Saint-Louis, 75010 Paris, France.
2
Laboratoire de Chimie Organique
3
Service de Néphrologie, Hôpital Foch, 92151
Suresnes, France.
4
Laboratoire d'Explorations Endocriniennes,
Hôpital Trousseau, 75012 Paris, France.
5
Service des Molécules Marquées, CEA/Saclay,
91191 Gif-sur-Yvette, France.
6
Department of Biochemistry and National Diagnostics
Centre, University College, Galway, Ireland.
7
Biochimie, Faculté de Pharmacie, 75006 Paris,
France.
a Address correspondence to this author at: Laboratoire de Biochimie Hormonale, Hôpital Saint-Louis, 1 ave. Claude-Vellefaux, 75475 Paris cédex 10, France. Fax + 33 1 42 49 42 80; e-mail bio.horm.fiet{at}chu-stlouis.fr
We have developed a new assay for cortisone (E) in serum, saliva, and urine involving Celite® chromatography followed by RIA with 125I-labeled E and scintillation proximity assay. The chromatography step separates cortisol (F) from E, and in combination with their RIAs, permits assessment of the status of the FE shuttle. We report the results of basal, postcorticotropin (ACTH), and postdexamethasone E and F concentrations and their circadian fluctuations in the serum, saliva, and urine of healthy volunteers. The serum and urine F/E ratios were increased in patients with ectopic ACTH secretion, whereas in adrenal adenoma and Cushing disease only the urinary ratio was increased. In chronic renal insufficiency this ratio was increased in serum (23.5 ± 3.9) but diminished in saliva (0.38 ± 0.11), and in apparent mineralocorticoid excess the ratios were high in serum (44.3 ± 9.3) and urine (5.35 ± 0.85) compared with those of healthy subjects (serum 9.8 ± 3.5, urine 0.52 ± 0.29, saliva 0.52 ± 0.29).
Key Words: indexing terms: scintillation proximity assay apparent mineralocorticoid excess 11ß-hydroxysteroid dehydrogenase Cushing syndrome
The following articles in journals at HighWire Press have cited this article:
![]() |
A. C Heijboer, F. Martens, and M. A Blankenstein Measuring salivary cortisol with the Architect i2000 random access analyser Ann Clin Biochem, May 1, 2009; 46(3): 261 - 262. [Full Text] [PDF] |
||||
![]() |
N. S. Sieber-Ruckstuhl, F. S. Boretti, M. Wenger, C. Maser-Gluth, and C. E. Reusch Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane Vet Rec., October 18, 2008; 163(16): 477 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Quinkler, D. Zehnder, J. Lepenies, M. D Petrelli, J. S Moore, S. V Hughes, P. Cockwell, M. Hewison, and P. M Stewart Expression of renal 11{beta}-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function Eur. J. Endocrinol., August 1, 2005; 153(2): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pardee, J. Reinking, and H. Krause Nuclear Hormone Receptors, Metabolism, and Aging: What Goes Around Comes Around Sci. Aging Knowl. Environ., November 24, 2004; 2004(47): re8 - re8. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fenske How Much "Urinary Free Cortisol" Is Really Cortisol during Water Diuresis in Healthy Individuals? Clin. Chem., June 1, 2004; 50(6): 1102 - 1104. [Full Text] [PDF] |
||||
![]() |
B. Bocchi, S. Kenouch, M. Lamarre-Cliche, M. Muffat-Joly, M. H. Capron, J. Fiet, G. Morineau, M. Azizi, J. P. Bonvalet, and N. Farman Impaired 11-{beta} Hydroxysteroid Dehydrogenase Type 2 Activity in Sweat Gland Ducts in Human Essential Hypertension Hypertension, April 1, 2004; 43(4): 803 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. V. Ward, H. E. Syddall, P. J. Wood, G. P. Chrousos, and D. I. W. Phillips Fetal Programming of the Hypothalamic-Pituitary-Adrenal (HPA) Axis: Low Birth Weight and Central HPA Regulation J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1227 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Carvajal, A. A. Gonzalez, D. G. Romero, A. Gonzalez, L. M. Mosso, E. T. Lagos, M. d. P. Hevia, M. P. Rosati, T. O. Perez-Acle, C. E. Gomez-Sanchez, et al. Two Homozygous Mutations in the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene in a Case of Apparent Mineralocorticoid Excess J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2501 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weber, S. Lewicka, M. Deuschle, M. Colla, P. Vecsei, and I. Heuser Increased Diurnal Plasma Concentrations of Cortisone in Depressed Patients J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1133 - 1136. [Abstract] [Full Text] |
||||
![]() |
G. Morineau, J.-M. Marc, A. Boudi, H. Galons, M. Gourmelen, P. Corvol, L. Pascoe, and J. Fiet Genetic, Biochemical, and Clinical Studies of Patients With A328V or R213C Mutations in 11{beta}HSD2 Causing Apparent Mineralocorticoid Excess Hypertension, September 1, 1999; 34(3): 435 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.Y. Andersen, G. Morineau, M. Fukuda, L.G. Westergaard, H.J. Ingerslev, J. Fiet, and A.G. Byskov Assessment of the follicular cortisol:cortisone ratio Hum. Reprod., June 1, 1999; 14(6): 1563 - 1568. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |